TapImmune Inc Stock Nasdaq
Equities
US8760334081
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | 9.01M | Sales 2023 | 3.31M | Capitalization | 48.89M |
---|---|---|---|---|---|
Net income 2022 | -29M | Net income 2023 | -8M | EV / Sales 2022 | 2.06 x |
Net cash position 2022 | 4.17M | Net cash position 2023 | 15.11M | EV / Sales 2023 | 10.2 x |
P/E ratio 2022 |
-0.74
x | P/E ratio 2023 |
-5.88
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.83% |
Latest transcript on TapImmune Inc
Managers | Title | Age | Since |
---|---|---|---|
Juan F. Vera
CEO | Chief Executive Officer | 44 | 18-10-16 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 19-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 18-10-16 | |
Steven Elms
BRD | Director/Board Member | 60 | 19-08-05 |
Katharine Knobil
BRD | Director/Board Member | 60 | 21-12-07 |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.84B | |
+46.79% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |